IDT Biologika agrees to produce Astra’s COVID vaccine

IDT Biologika agrees to produce over 10 million doses of AstraZeneca’s COVID – 19 vaccine :

IDT Biologika has recently announced its plan to manufacture around 10 million doses of AstraZeneca’s COVID – 19 vaccine. The German vaccine – maker made this announcement on 16 April 2021 and added that IDT would produce the doses in 2021. Read- AstraZeneca covid 19 vaccine update: EU’s warning

IDT and AstraZeneca had previously stated that they would expand the production of AstraZeneca’s vaccine by the end of 2022. It was revealed that the additional production will be carried out at a plant in the German town of Dessau.¹

The recent agreement to produce 10 million doses was due to Merz Pharma relinquishing its production deal with IDT. This third manufacturer had previously reserved the production capacity for the second quarter with IDT.

IDT is actively involved in making vaccines for several pharmaceutical companies. It had also announced that it would manufacture the single – dose COVID – 19 shot of J&J^[1] for three months in March 2021. Read about- Johnson & Johnson’s COVID vaccine

The company’s CEO^[2] had further stated that the company was in talks with the developers of Sputnik V shot. This information was revealed on 16 April 2021. Russia’s Sputnik V is yet to be approved by the European Union.

In Germany, AstraZeneca’s COVID – 19 shot is restricted to people over 60 years of age. This is due to some concerns over blood clots in some recipients.

Abbreviation :